Literature DB >> 30319196

Increased Nuclear Factor-κB/RelA Expression Levels in Human Colorectal Carcinoma in North Indian Patients.

Ram Rattan Negi1, Satya Vati Rana2, Rajesh Gupta3, Vikas Gupta3, Vijayta D Chadha4, Devinder K Dhawan1.   

Abstract

Colorectal cancer is a major cause of cancer-related death in many countries. Inflammatory pathway is considered to play a major role in colorectal carcinogenesis. Nuclear factor kappa B (NF-κB) pathway is a link between inflammation and cancer. NF-κB is a transcription factor which belongs to the Rel family. Activation of NF-κB has been shown to play a role in cell proliferation, apoptosis, cytokine production, and oncogenesis. The aim of the present study was to evaluate the expression levels of NF-κB/RelA in colorectal carcinoma using Real-time PCR. For this study, tumor tissue was taken from general surgery OT of PGIMER, Chandigarh from twenty-seven patients of colorectal cancer treated by surgery. Adjacent colonic mucosa specimens were also collected from all patients as normal control tissue. Real-time PCR was performed to determine the nuclear factor-κB/RelA expression levels in twenty-seven pairs of colorectal adenocarcinoma and adjacent normal colonic tissues. Out of 27 CRC patients, 18 were males and 9 females. Mean age of patients was 51.1 ± 14.8 years. Most of the cases were males (67%). Seventy percent of the cases were early (I-II) and 30% were advanced (III-IV) tumor stage. The quantitative relative expression of NF-kB mRNA was found to be significantly higher (p < 0.05) in CRC tissues as compared with that in adjacent normal colon tissues. From this study, we can conclude that RelA/NF-kB pathway is expressed constitutively in colorectal adenoma and adenocarcinomas. Thus, RelA/NF-kB might play an important role in colorectal tumorigenesis.

Entities:  

Keywords:  Colorectal cancer; Gene expression; Nuclear factor-κB; Real-time polymerase chain reaction

Year:  2017        PMID: 30319196      PMCID: PMC6170227          DOI: 10.1007/s12291-017-0703-0

Source DB:  PubMed          Journal:  Indian J Clin Biochem        ISSN: 0970-1915


  16 in total

Review 1.  NF-kappaB family of transcription factors: central regulators of innate and adaptive immune functions.

Authors:  Jorge Caamaño; Christopher A Hunter
Journal:  Clin Microbiol Rev       Date:  2002-07       Impact factor: 26.132

Review 2.  Multiple signals converging on NF-kappaB.

Authors:  F Mercurio; A M Manning
Journal:  Curr Opin Cell Biol       Date:  1999-04       Impact factor: 8.382

Review 3.  Nuclear factor-kappaB activation: a question of life or death.

Authors:  Shishir Shishodia; Bharat B Aggarwal
Journal:  J Biochem Mol Biol       Date:  2002-01-31

4.  A novel method for real time quantitative RT-PCR.

Authors:  U E Gibson; C A Heid; P M Williams
Journal:  Genome Res       Date:  1996-10       Impact factor: 9.043

Review 5.  Molecular Alterations of Colorectal Cancer with Inflammatory Bowel Disease.

Authors:  Masakazu Yashiro
Journal:  Dig Dis Sci       Date:  2015-04-04       Impact factor: 3.199

Review 6.  NF-kappaB in cancer: from innocent bystander to major culprit.

Authors:  Michael Karin; Yixue Cao; Florian R Greten; Zhi-Wei Li
Journal:  Nat Rev Cancer       Date:  2002-04       Impact factor: 60.716

7.  Colorectal cancer statistics, 2017.

Authors:  Rebecca L Siegel; Kimberly D Miller; Stacey A Fedewa; Dennis J Ahnen; Reinier G S Meester; Afsaneh Barzi; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2017-03-01       Impact factor: 508.702

8.  Nuclear factor-kappa B is upregulated in colorectal cancer.

Authors:  D S Lind; S N Hochwald; J Malaty; S Rekkas; P Hebig; G Mishra; L L Moldawer; E M Copeland; S Mackay
Journal:  Surgery       Date:  2001-08       Impact factor: 3.982

9.  Mechanism of colon cancer cell apoptosis mediated by pyropheophorbide-a methylester photosensitization.

Authors:  J Y Matroule; C M Carthy; D J Granville; O Jolois; D W Hunt; J Piette
Journal:  Oncogene       Date:  2001-07-05       Impact factor: 9.867

10.  Increased nuclear factor-kB activation in human colorectal carcinoma and its correlation with tumor progression.

Authors:  Masayuki Kojima; Takashi Morisaki; Nobuhiko Sasaki; Kenji Nakano; Ryuichi Mibu; Masao Tanaka; Mitsuo Katano
Journal:  Anticancer Res       Date:  2004 Mar-Apr       Impact factor: 2.480

View more
  2 in total

Review 1.  From inflammatory bowel disease to colorectal cancer: what's the role of miRNAs?

Authors:  Mostafa Vaghari-Tabari; Niloufar Targhazeh; Soheila Moein; Durdi Qujeq; Forough Alemi; Maryam Majidina; Simin Younesi; Zatollah Asemi; Bahman Yousefi
Journal:  Cancer Cell Int       Date:  2022-04-11       Impact factor: 5.722

2.  Over-Expression of Cyclooxygenase-2 in Colorectal Cancer Patients.

Authors:  Ram Rattan Negi; Satya Vati Rana; Vikas Gupta; Rajesh Gupta; Vijayta Dani Chadha; Kaushal Kishor Prasad; Devinder K Dhawan
Journal:  Asian Pac J Cancer Prev       Date:  2019-06-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.